Literature DB >> 17125174

Modeling robust QSAR.

Jaroslaw Polanski1, Andrzej Bak, Rafal Gieleciak, Tomasz Magdziarz.   

Abstract

Quantitative Structure Activity Relationship (QSAR) is a term describing a variety of approaches that are of substantial interest for chemistry. This method can be defined as indirect molecular design by the iterative sampling of the chemical compounds space to optimize a certain property and thus indirectly design the molecular structure having this property. However, modeling the interactions of chemical molecules in biological systems provides highly noisy data, which make predictions a roulette risk. In this paper we briefly review the origins for this noise, particularly in multidimensional QSAR. This was classified as the data, superimposition, molecular similarity, conformational, and molecular recognition noise. We also indicated possible robust answers that can improve modeling and predictive ability of QSAR, especially the self-organizing mapping of molecular objects, in particular, the molecular surfaces, a method that was brought into chemistry by Gasteiger and Zupan.

Mesh:

Year:  2006        PMID: 17125174     DOI: 10.1021/ci050314b

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  22 in total

1.  Toward better QSAR/QSPR modeling: simultaneous outlier detection and variable selection using distribution of model features.

Authors:  Dongsheng Cao; Yizeng Liang; Qingsong Xu; Yifeng Yun; Hongdong Li
Journal:  J Comput Aided Mol Des       Date:  2010-11-13       Impact factor: 3.686

Review 2.  In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

3.  Side-chain conformational space analysis (SCSA): a multi conformation-based QSAR approach for modeling and prediction of protein-peptide binding affinities.

Authors:  Peng Zhou; Xiang Chen; Zhicai Shang
Journal:  J Comput Aided Mol Des       Date:  2008-10-08       Impact factor: 3.686

4.  QSAR model based on weighted MCS trees approach for the representation of molecule data sets.

Authors:  Bernardo Palacios-Bejarano; Gonzalo Cerruela García; Irene Luque Ruiz; Miguel Ángel Gómez-Nieto
Journal:  J Comput Aided Mol Des       Date:  2013-02-06       Impact factor: 3.686

5.  Design, Synthesis, and Evaluation of Novel 3-Carboranyl-1,8-Naphthalimide Derivatives as Potential Anticancer Agents.

Authors:  Sebastian Rykowski; Dorota Gurda-Woźna; Marta Orlicka-Płocka; Agnieszka Fedoruk-Wyszomirska; Małgorzata Giel-Pietraszuk; Eliza Wyszko; Aleksandra Kowalczyk; Paweł Stączek; Andrzej Bak; Agnieszka Kiliszek; Wojciech Rypniewski; Agnieszka B Olejniczak
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

6.  Receptor independent and receptor dependent CoMSA modeling with IVE-PLS: application to CBG benchmark steroids and reductase activators.

Authors:  Tomasz Magdziarz; Pawel Mazur; Jaroslaw Polanski
Journal:  J Mol Model       Date:  2008-10-21       Impact factor: 1.810

7.  Proline-Based Carbamates as Cholinesterase Inhibitors.

Authors:  Hana Pizova; Marketa Havelkova; Sarka Stepankova; Andrzej Bak; Tereza Kauerova; Violetta Kozik; Michal Oravec; Ales Imramovsky; Peter Kollar; Pavel Bobal; Josef Jampilek
Journal:  Molecules       Date:  2017-11-14       Impact factor: 4.411

8.  Quantum chemical predictions of water-octanol partition coefficients applied to the SAMPL6 logP blind challenge.

Authors:  Michael R Jones; Bernard R Brooks
Journal:  J Comput Aided Mol Des       Date:  2020-01-30       Impact factor: 3.686

Review 9.  Two Decades of 4D-QSAR: A Dying Art or Staging a Comeback?

Authors:  Andrzej Bak
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

10.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications.

Authors:  Mingzhu Zhao; Qiang Zhou; Wanghao Ma; Dong-Qing Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.